Exploring in-hospital clinical outcomes among acute myocardial infarction patients with prior COVID-19 history.

Kamal Sharma, Iva Patel, Rujuta Parikh, Maulik Kalyani, Khamir Banker, Dixit Dhorajiya, Apoorva M
Author Information
  1. Kamal Sharma: Department of Cardiology, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID
  2. Iva Patel: Research Department, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID
  3. Rujuta Parikh: Department of Cardiology, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID
  4. Maulik Kalyani: Department of Cardiology, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID
  5. Khamir Banker: Research Department, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID
  6. Dixit Dhorajiya: Department of Cardiology, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID
  7. Apoorva M: Department of Cardiology, U.N.Mehta Institute of Cardiology and Research Centre (UNMICRC), Civil Hospital Campus, Asarwa, Ahmedabad-380016, Gujarat, India. ORCID

Abstract

Introduction: Limited real-world data exist regarding cardiovascular outcomes in post-COVID-19 individuals following discharge, particularly within the Asian Indian population. This study aims to explore the association between prior COVID-19 history and in-hospital outcomes in acute myocardial infarction patients.
Methods: Hospital database was searched for the patients who were diagnosed with Acute myocardial infarction (AMI) and were grouped according to absence (Group-A) or presence (Group-B) of history of severe COVID-19 hospitalization at least 3 months prior to the index event of AMI. Study primary endpoint was defined as major adverse cardiovascular events (MACE) comprising of Re-AMI, stroke, death (3P) and acute decompensated heart failure (4P), which were analyzed between these 2 study groups.
Results: Of 10,581 consecutive patients of AMI, 5.33% (n=564/10,581) patients had prior history of severe SARS-CoV-2 hospitalization beyond 3 months of index AMI. Past severe Covid-19 patients presenting with AMI were more likely to be younger (59.12+11.23 years vs. 52.01+10.05 years) and younger than 40 years of age. Patients in Group B demonstrated a notably higher prevalence of diabetes, hypertension, higher Killip class, and lower presenting LVEF compared to Group A. In-hospital cardiac arrest, stroke, heart failure and all-cause death were significantly higher in Group B patients. Higher unadjusted odds ratio for in hospital death OR=5.78 (2.56-10.23), 3-P MACE OR=2.33 (1.23-8.65) and 4-P MACE OR=2.58 (1.36-5.43) were found in patients with prior history of COVID-19. After adjusting for comorbidities, the ratio for in-hospital MACE was found to be non-significant.
Conclusion: Conventional risk factors and presence of comorbidities in individuals with prior history of COVID-19 hospitalization increased the risk of both 3P and 4P MACE during AMI.

Keywords

References

  1. Can J Cardiol. 2023 Jun;39(6):726-740 [PMID: 36754119]
  2. Hypertension. 2020 Oct;76(4):1104-1112 [PMID: 32673499]
  3. PLoS Med. 2022 Jul 19;19(7):e1004052 [PMID: 35853019]
  4. J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264 [PMID: 30153967]
  5. J Cardiovasc Thorac Res. 2023;15(2):93-97 [PMID: 37654814]
  6. Diagnostics (Basel). 2023 Jan 29;13(3): [PMID: 36766599]
  7. Int J Pept. 2012;2012:256294 [PMID: 22536270]
  8. Rev Esp Cardiol (Engl Ed). 2022 Jan;75(1):100-102 [PMID: 34583913]
  9. Am Heart J Plus. 2023 Jan;25:100243 [PMID: 36570777]
  10. Crit Care. 2020 Jul 13;24(1):422 [PMID: 32660650]
  11. JAMA. 2020 Aug 11;324(6):603-605 [PMID: 32644129]
  12. Expert Rev Anti Infect Ther. 2021 Mar;19(3):345-357 [PMID: 32921216]
  13. Nat Rev Cardiol. 2022 May;19(5):332-341 [PMID: 34686843]
  14. Nat Med. 2022 Mar;28(3):583-590 [PMID: 35132265]
  15. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):444-446 [PMID: 34824040]
  16. Curr Probl Cardiol. 2023 Apr;48(4):101547 [PMID: 36528206]
  17. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):677-686 [PMID: 34519777]
  18. Rev Esp Cardiol (Engl Ed). 2022 Aug;75(8):669-680 [PMID: 35067471]
  19. JACC Basic Transl Sci. 2022 Mar;7(3):294-308 [PMID: 35165665]

Word Cloud

Created with Highcharts 10.0.0patientsAMIpriorCOVID-19historyMACEoutcomesin-hospitalacutemyocardialinfarctionseverehospitalizationdeathyearsGrouphighercardiovascularindividualsstudypresence3monthsindexstroke3Pheartfailure4P2581SARS-CoV-2presentingyounger23BratioOR=21foundcomorbiditiesriskfactorsIntroduction:Limitedreal-worlddataexistregardingpost-COVID-19followingdischargeparticularlywithinAsianIndianpopulationaimsexploreassociationMethods:HospitaldatabasesearcheddiagnosedAcutegroupedaccordingabsenceGroup-AGroup-BleasteventStudyprimaryendpointdefinedmajoradverseeventscomprisingRe-AMIdecompensatedanalyzedgroupsResults:10consecutive533%n=564/10beyondPastCovid-19likely5912+11vs5201+100540agePatientsdemonstratednotablyprevalencediabeteshypertensionKillipclasslowerLVEFcomparedIn-hospitalcardiacarrestall-causesignificantlyHigherunadjustedoddshospitalOR=57856-103-P3323-8654-P5836-543adjustingnon-significantConclusion:ConventionalincreasedExploringclinicalamongLongCOVIDRiskSevere

Similar Articles

Cited By

No available data.